Every AI express, investors ask questions on the investor interaction platform: Hello, does your company have a heavy-duty adult vaccine? How does the company plan for adult heavy varieties?
Shenzhen Kangtai Biological Products Co.Ltd(300601) (300601. SZ) said on the investor interaction platform on January 29 that after years of unremitting independent R & D and innovation, the company has formed a vaccine product echelon with complete R & D varieties, rich product lines and obvious technical advantages. The adult vaccines currently on the market include 20 μ G hepatitis B vaccine, 60 μ G hepatitis B vaccine, 23-Valent Pneumococcal Polysaccharide Vaccine, COVID-19 inactivated vaccine, COVID-19 adenovirus vector vaccine and so on. The company pays attention to the layout and development of multi linked and multivalent vaccines and new vaccines, and steadily promotes the R & D process and industrialization of research projects. At present, the freeze-dried human rabies vaccine (human diploid cells) has received the registration on-site verification notice from the drug evaluation center of the State Drug Administration, and the registration on-site verification will begin. The freeze-dried live attenuated varicella vaccine has completed the on-site work of phase III clinical research, The clinical trials of Sabin strain inactivated polio vaccine (Vero cell), adsorbed acellular DPT (component) combined vaccine and other vaccines were carried out in an orderly manner, adsorbed acellular DPT inactivated poliomyelitis and Haemophilus influenzae type B combined vaccine, adsorbed acellular DPT inactivated poliomyelitis combined vaccine The oral pentavalent reconstituted live attenuated rotavirus vaccine (Vero cell) has obtained the clinical trial approval, and the preparation of the clinical trial is in progress. At the same time, the company has arranged to develop tetravalent hand, foot and mouth disease vaccine, mumps fengshuipox vaccine, tetravalent influenza vaccine, 20 valent pneumococcal polysaccharide binding vaccine and other multivalent vaccines.
